TargetMol

Perifosine

Product Code:
 
TAR-T2492
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T2492-2mg2mg£102.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2492-5mg5mg£121.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2492-10mg10mg£136.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2492-25mg25mg£201.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2492-50mg50mg£309.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2492-100mg100mg£446.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Perifosine is an oral-active, alkyl-phosphocholine Akt inhibitor with potential antineoplastic activity.
CAS:
157716-52-4
Formula:
C25H52NO4P
Molecular Weight:
461.668
Pathway:
Apoptosis; PI3K/Akt/mTOR signaling; Autophagy; Cytoskeletal Signaling
Purity:
0.9994
SMILES:
CCCCCCCCCCCCCCCCCCOP([O-])(=O)OC1CC[N+](C)(C)CC1
Target:
Apoptosis; Akt; Autophagy

References

1. Vyomesh Patel, et al. Cancer Res, 2002, 62(5), 1401-1409 2. Momota H, et al. Cancer Res, 2005, 65(16), 7429-7435. 3. Hideshima T, et al. Blood, 2006, 107(10), 4053-4062. 4. Fei HR, et al. Cytotechnology, 2010, 62(5), 449-460 5. Catley L, et al. Exp Hematol, 2007, 32(7), 1038-1046